Antiviral Product Development--Conducting and Submitting Virology Studies to the Agency: Guidance for Submitting HCV Resistance Data
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 2, 2006
April 9, 2020
3b53e257-72e5-402a-9e6e-a5abd8c1a7a8
Related Documents
Antiviral Product Development--Conducting and Submitting Virology Studies to the Agency: Guidance for Submitting HBV Resistance Data
Guidance DocumentJune 2, 2006Center for Drug Evaluation and Research
Antiviral Product Development--Conducting and Submitting Virology Studies to the Agency : Guidance for Submitting Influenza Resistance Data
Guidance DocumentJune 2, 2006Center for Drug Evaluation and Research
Antiviral Product Development--Conducting and Submitting Virology Studies to the Agency: Guidance for Submitting HIV Resistance Data
Guidance DocumentJune 2, 2006Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox